Quote
Email Us
Therapeutic Oligos

Therapeutic Oligos
Targeted Molecular Interventions

Advance your therapeutic programs with high-purity, chemically modified ASOs, siRNAs, and miRNAs designed for enhanced stability and efficacy.
Therapeutic Oligos

Overview

Therapeutic oligonucleotides, such as ASOs, siRNAs, and miRNAs, represent a powerful class of drugs that modulate gene expression with high specificity. Tsingke provides comprehensive services for the design, synthesis, and modification of these molecules, supporting your efforts from early research to clinical development.

Challenges

1

Achieving sufficient cellular uptake and endosomal escape

2

Mitigating off-target effects and immune stimulation

3

Ensuring stability in vivo for durable effects

4

The synthesis process is complex and scaling up production incurs high costs.

Tsingke Solutions

ASO Synthesis

Antisense oligonucleotides with a variety of backbone and sugar modifications (e.g., PS, MOE, LNA).

siRNA/miRNA Services

Dual-stranded RNAs with chemical modifications (e.g., 2'-F, 2'-O-Me) for improved stability and RISC loading.

Custom Modifications

A wide range of chemical modifications and conjugate options (e.g., GalNAc, cholesterol).

Analytical Services

Comprehensive QC including HPLC, MS, and functional assays.

Why Tsingke?

Deep Expertise

Extensive experience in synthesizing complex, modified oligonucleotides.

Scalable Production

Capabilities from research-grade to GMP-level manufacturing.

Proven Performance

Oligos are functionally validated in relevant cellular models.

Successful Delivery

Successful delivery of multiple strategic partnerships and numerous mg/g/kg-scale orders with guaranteed quality

Contact Us
Develop potent and specific oligonucleotide therapeutics.
Partner with Tsingke for your oligo discovery and development.
Tsingke Updates
pop_close
pop_main
Subscribe to Our Newsletter

Stay updated with the latest industry news and expert insights. 

Subscribe now to receive:
        ● Industry updates
        ● Exclusive expert insights and analysis
Enter your email to stay ahead!

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept